Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  112 results for ""Hydroxycholecalciferols""

Your Filters

Subject : hyperparathyroidism, secondary
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.

  • Authors : Rauscher S; Division of Nephrology, Maisonneuve-Rosemont HospitalUniversity of Montreal, 5415 Assomption Blvd, Montreal, QC, H1T 2M4, Canada.; Lafrance JP

Subjects: Calcitriol*/Calcitriol*/Calcitriol*/administration & dosage ; Calcitriol*/Calcitriol*/Calcitriol*/pharmacokinetics ; Hydroxycholecalciferols*/Hydroxycholecalciferols*/Hydroxycholecalciferols*/administration & dosage

  • Source: International urology and nephrology [Int Urol Nephrol] 2017 Feb; Vol. 49 (2), pp. 325-328. Date of Electronic Publication: 2016 Nov 08.Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease].

  • Authors : Ureña-Torres PA; Ramsay générale de santé, service de néphrologie et dialyse, clinique du Landy, 23, rue du Landy, 93400 Saint-Ouen, France; Department of renal physiology, Necker hospital, university of Paris Descartes, 75015 Paris, France. Electronic address: .

Subjects: Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*therapeutic use ; Chronic Kidney Disease-Mineral and Bone Disorder/Chronic Kidney Disease-Mineral and Bone Disorder/Chronic Kidney Disease-Mineral and Bone Disorder/*drug therapy ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use

  • Source: Nephrologie & therapeutique [Nephrol Ther] 2018 Jun; Vol. 14 (4), pp. 189-200. Date of Electronic Publication: 2018 Mar 12.Publisher: John Libbey Eurotext Country of Publication: France NLM ID: 101248950 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate.

  • Authors : Kitsos A; Department of Nephrology, University of Ioannina, Ioannina, Greece.; Dounousi E

Subjects: Glomerular Filtration Rate*; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*blood ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*blood

  • Source: Hormones (Athens, Greece) [Hormones (Athens)] 2018 Jun; Vol. 17 (2), pp. 237-246. Date of Electronic Publication: 2018 Apr 17.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101142469 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients - a randomized study.

Subjects: Calcitriol/Calcitriol/Calcitriol/*analogs & derivatives ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy

  • Source: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2014 May; Vol. 52 (5), pp. 360-8.Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.

  • Authors : Alghareeb A; Prince Salman Center for Kidney Diseases, Riyadh, Kingdom of Saudi Arabia. ; Sabry A

Subjects: Renal Dialysis*; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*administration & dosage ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy

  • Source: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Publisher: Blackwell Pub Country of Publication: Australia NLM ID: 101181252 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients.

  • Authors : Kiattisunthorn K; Division of Nephrology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. ; Wutyam K

Subjects: Renal Dialysis*; Calcimimetic Agents/Calcimimetic Agents/Calcimimetic Agents/*administration & dosage ; Calcitriol/Calcitriol/Calcitriol/*administration & dosage

  • Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2011 Mar; Vol. 16 (3), pp. 277-84.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol.

  • Authors : Kubodera N; Chugai Pharmaceutical Co., Ltd., 2-1-1, Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-8324, Japan.

Subjects: Ergocalciferols/Ergocalciferols/Ergocalciferols/*chemistry ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*chemistry ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy

  • Source: Molecules (Basel, Switzerland) [Molecules] 2009 Sep 29; Vol. 14 (10), pp. 3869-80. Date of Electronic Publication: 2009 Sep 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial.

  • Authors : Hansen D; Section of Nephrology, Department of Medicine, Roskilde Hospital, Roskilde, Denmark. ; Rasmussen K

Subjects: Ergocalciferols/Ergocalciferols/Ergocalciferols/*therapeutic use ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy

  • Source: Kidney international [Kidney Int] 2011 Oct; Vol. 80 (8), pp. 841-50. Date of Electronic Publication: 2011 Aug 10.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.

  • Authors : Reichel H; Nephrological Center, Villingen-Schwenningen, Germany.

Subjects: Renal Dialysis*; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*administration & dosage ; Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/Hyperparathyroidism, Secondary/*drug therapy

  • Source: Nephron. Clinical practice [Nephron Clin Pract] 2010; Vol. 114 (4), pp. c268-76. Date of Electronic Publication: 2010 Jan 20.Publisher: Karger Country of Publication: Switzerland NLM ID: 101159763 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.

  • Authors : Moe S; 1Department of Pharmacy, Toronto East General Hospital, Toronto, Canada.; Wazny LD

Subjects: Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*therapeutic use ; Calcitriol/Calcitriol/Calcitriol/*therapeutic use ; Hydroxycholecalciferols/Hydroxycholecalciferols/Hydroxycholecalciferols/*therapeutic use

  • Source: The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique [Can J Clin Pharmacol] 2008 Winter; Vol. 15 (1), pp. e36-43. Date of Electronic Publication: Publisher: Pulsus Group [for the] Canadian Society for Clinical Pharmacology Country of Publication: Canada NLM ID: 9804162 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
  • 1-10 of  112 results for ""Hydroxycholecalciferols""